118 related articles for article (PubMed ID: 9730455)
1. Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular Surgery.
Konety BR; Tewari A; Howard RJ; Barry JM; Hodge EE; Taylor R; Jordan ML
Urology; 1998 Sep; 52(3):428-32. PubMed ID: 9730455
[TBL] [Abstract][Full Text] [Related]
2. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Management, and Clinical Outcomes of Prostate Cancer in Kidney Transplant Recipients.
Haroon UH; Davis NF; Mohan P; Little DM; Smyth G; Forde JC; Power RE
Exp Clin Transplant; 2019 Jun; 17(3):298-303. PubMed ID: 30602361
[TBL] [Abstract][Full Text] [Related]
4. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
Aus G
Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
[TBL] [Abstract][Full Text] [Related]
7. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
9. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.
Kundu SD; Grubb RL; Roehl KA; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1116-20. PubMed ID: 15758718
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening and treatment in the transplant population: current status and recommendations.
Breyer BN; Whitson JM; Freise CE; Meng MV
J Urol; 2009 May; 181(5):2018-25; discussion 2025-6. PubMed ID: 19286214
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.
Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC
J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
Pettenati C; Jannot AS; Hurel S; Verkarre V; Kreis H; Housset M; Legendre C; Méjean A; Timsit MO
Clin Transplant; 2016 Aug; 30(8):964-71. PubMed ID: 27251769
[TBL] [Abstract][Full Text] [Related]
13. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
Richie JP; Catalona WJ; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; deKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
Urology; 1993 Oct; 42(4):365-74. PubMed ID: 7692657
[TBL] [Abstract][Full Text] [Related]
14. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 1994 May; 151(5):1283-90. PubMed ID: 7512659
[TBL] [Abstract][Full Text] [Related]
15. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
16. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics.
Krakowsky Y; Loblaw A; Klotz L
J Urol; 2010 Jul; 184(1):131-5. PubMed ID: 20478589
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
19. Radical retropubic prostatectomy in immunosuppressed transplant recipients.
Thompson RH; Leibovich BC; Karnes RJ; Bergstralh EJ; Blute ML
J Urol; 2008 Apr; 179(4):1349-52; discussion 1352-3. PubMed ID: 18289598
[TBL] [Abstract][Full Text] [Related]
20. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
